Scholarly Index

Kwok‐Yung Yuen

University of Hong Kong; 159,429 total citations; 1,485 total publications; best world rank #2

University of Hong Kong

159,429Total citations

1,485Total publications

158H-index

Published ranking records

Field	Window	World rank	National rank	Impact score
Medical and Health Sciences	Lifetime	570	CN 7	99.97
Infectious Diseases	Lifetime	10	CN 1	99.95
Epidemiology	Lifetime	40	CN 3	99.93
Animal Science and Livestock Production	Lifetime	374	CN 31	97.33
Clinical Biochemistry	Lifetime	313	CN 7	94.38
Endocrinology	Lifetime	391	CN 17	91.98
Molecular Medicine	Lifetime	384	CN 44	88.40
Microbiology	Lifetime	568	CN 16	85.39
Parasitology	Lifetime	770	CN 22	76.42
Infectious Diseases	2021-2025	21	CN 4	99.70
Epidemiology	2021-2025	745	CN 78	92.73
COVID-19 Clinical Research Studies	Lifetime	2	CN 2	99.97
SARS-CoV-2 and COVID-19 Research	Lifetime	2	CN 2	99.98
SARS-CoV-2 detection and testing	Lifetime	5	CN 3	99.78
Viral gastroenteritis research and epidemiology	Lifetime	19	CN 2	99.89
Animal Virus Infections Studies	Lifetime	26	CN 2	99.77
Influenza Virus Research Studies	Lifetime	28	CN 4	99.79
Respiratory viral infections research	Lifetime	37	CN 4	99.78
Mycobacterium research and diagnosis	Lifetime	60	CN 1	99.42
Streptococcal Infections and Treatments	Lifetime	101	CN 1	99.18
Long-Term Effects of COVID-19	Lifetime	212	CN 13	98.04
Fungal Infections and Studies	Lifetime	128	CN 1	99.01
Bacterial Identification and Susceptibility Testing	Lifetime	155	CN 5	99.07
Viral Infections and Immunology Research	Lifetime	240	CN 3	98.45
COVID-19 epidemiological studies	Lifetime	173	CN 19	98.51
Animal Disease Management and Epidemiology	Lifetime	218	CN 13	98.62
Infective Endocarditis Diagnosis and Management	Lifetime	260	CN 4	98.96
Antifungal resistance and susceptibility	Lifetime	243	CN 3	98.62
Infectious Diseases and Tuberculosis	Lifetime	197	CN 2	98.07
Tuberculosis Research and Epidemiology	Lifetime	544	CN 15	98.12
Antibiotic Resistance in Bacteria	Lifetime	706	CN 40	98.06
Pneumocystis jirovecii pneumonia detection and treatment	Lifetime	424	CN 2	97.81
Viral Infections and Vectors	Lifetime	791	CN 29	97.75
interferon and immune responses	Lifetime	509	CN 45	96.79
Antimicrobial Resistance in Staphylococcus	Lifetime	601	CN 9	97.47
Infection Control and Ventilation	Lifetime	177	CN 42	96.33
Infectious Diseases and Mycology	Lifetime	317	CN 3	95.95
COVID-19 and healthcare impacts	Lifetime	999	CN 41	91.79
Burkholderia infections and melioidosis	Lifetime	85	CN 2	95.86
Infections and bacterial resistance	Lifetime	136	CN 7	94.56
Actinomycetales infections and treatment	Lifetime	135	CN 7	92.60
Polyomavirus and related diseases	Lifetime	898	CN 9	93.97
Infection Control in Healthcare	Lifetime	503	CN 15	88.45
Diphtheria, Corynebacterium, and Tetanus	Lifetime	654	CN 11	82.30
Infectious Disease Case Reports and Treatments	Lifetime	957	CN 18	60.76
SARS-CoV-2 and COVID-19 Research	2021-2025	27	CN 4	99.78
COVID-19 Clinical Research Studies	2021-2025	41	CN 5	99.69
SARS-CoV-2 detection and testing	2021-2025	47	CN 12	98.32
Viral gastroenteritis research and epidemiology	2021-2025	175	CN 41	95.97
Long-Term Effects of COVID-19	2021-2025	669	CN 27	94.64
Respiratory viral infections research	2021-2025	474	CN 31	92.95
Animal Virus Infections Studies	2021-2025	558	CN 249	89.21
Influenza Virus Research Studies	2021-2025	544	CN 79	89.76
Infection Control and Ventilation	2021-2025	467	CN 165	83.73
interferon and immune responses	2021-2025	880	CN 482	81.19
Hepatitis Viruses Studies and Epidemiology	2021-2025	468	CN 80	76.78
vaccines and immunoinformatics approaches	2021-2025	930	CN 142	73.65